(Q41627640)

5 October 2017

0 references

Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review (English)

1 reference

5 October 2017

1 reference

lymphoblastic leukemia

1 reference

Gaynon PS

1

1 reference

5 October 2017

Desai AA

2

1 reference

5 October 2017

Bostrom BC

3

1 reference

5 October 2017

Hutchinson RJ

4

1 reference

5 October 2017

Lange BJ

5

1 reference

5 October 2017

Nachman JB

6

1 reference

5 October 2017

Reaman GH

7

1 reference

5 October 2017

Sather HN

8

1 reference

5 October 2017

Steinherz PG

9

1 reference

5 October 2017

Trigg ME

10

1 reference

5 October 2017

Tubergen DG

11

1 reference

5 October 2017

Uckun FM

12

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

5 October 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

5 October 2017

80

1 reference

5 October 2017

1717-1726

1 reference

5 October 2017

9

1 reference

Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review

5 October 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Prognostic factors in osteosarcoma: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Which treatment for childhood acute lymphoblastic leukaemia in second remission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Genomic imprinting, DNA methylation, and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

[Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

LSA2-L2 protocol treatment of stage IV non-Hodgkin's lymphoma in children with partial and extensive bone marrow involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Cytoreduction and prognosis in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

The molecular basis of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971101%2980%3A9%3C1717%3A%3AAID-CNCR4%3E3.0.CO%3B2-B

10.1002/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference